Search

Your search keyword '"Superti-Furga, Giulio"' showing total 1,338 results

Search Constraints

Start Over You searched for: Author "Superti-Furga, Giulio" Remove constraint Author: "Superti-Furga, Giulio"
1,338 results on '"Superti-Furga, Giulio"'

Search Results

Catalog

Books, media, physical & digital resources

5. Protein Binder Toolbox for Studies of Solute Carrier Transporters

8. Structural basis for recruitment of TASL by SLC15A4 in human endolysosomal TLR signaling

9. Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8

10. PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing

11. LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

16. Author Correction: PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing

18. Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells

20. EU-LIFE charter of independent life science research institutes

21. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9

22. The promise and peril of chemical probes

23. Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity.

25. Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation

26. Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulators

27. Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions

30. Identification and Characterization of Novel Small-Molecule Enhancers of the CUL3LZTR1E3 Ligase KRAS Complex

31. Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8

32. LZTR1 is a regulator of RAS ubiquitination and signaling

35. Polymerase [delta] deficiency causes syndromic immunodeficiency with replicative stress

39. Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

41. The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)

42. Discovery of Molecular Glue Degraders via Isogenic Morphological Profiling

43. Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

47. EU‐LIFE charter of independent life science research institutes.

48. Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

49. Absence of mitochondrial SLC25A51 enhances PARP1-dependent DNA repair by increasing nuclear NAD+ levels